menu
    • menu

    Company profile for Corsera Health

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Corsera Health is redefining the future of cardiovascular care through early prediction and prevention of atherosclerotic cardiovascular disease (ASCVD). The company is developing a once-annual RNAi therapy designed to prevent cumulative cardiovascular damage. By uniting decades of RNAi innovation with global expertise in disease prediction, manufacturing, evidence generation, and commercialization, Corsera Health aims to tran...
    Corsera Health is redefining the future of cardiovascular care through early prediction and prevention of atherosclerotic cardiovascular disease (ASCVD). The company is developing a once-annual RNAi therapy designed to prevent cumulative cardiovascular damage. By uniting decades of RNAi innovation with global expertise in disease prediction, manufacturing, evidence generation, and commercialization, Corsera Health aims to transform the management of heart disease—extending healthspan, reducing healthcare costs, and enhancing overall human productivity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Corsera Healthindia-flag Flag
    Country
    Country
    India
    Address
    Address
    101 Federal Street · Suite 1320 · Boston, MA 02110
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://corserahealth.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corsera Pursues Dual Strategy Against Top Cardiovascular Killer
    Corsera Pursues Dual Strategy Against Top Cardiovascular Killer

    24 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/corsera-eyes-two-pronged-approach-to-tackle-leading-cardiovascular-killer

    BIOSPACE
    24 Feb 2026
    Share Share
    Corsera Health Secures $80M Series A, Hits Key Milestone
    Corsera Health Secures $80M Series A, Hits Key Milestone

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106455881/en/Corsera-Health-Announces-%2480-Million-Series-A-Financing-and-Reaches-Key-Clinical-Milestone

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    Corsera Initiates First Phase 1 Trial For Cardiovascular Disease
    Corsera Initiates First Phase 1 Trial For Cardiovascular Disease

    27 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251024605879/en/Corsera-Health-Files-First-Phase-1-Clinical-Trial-Application-for-its-Lead-Preventive-RNAi-Medicine-Program-for-Cardiovascular-Disease

    BUSINESS WIRE
    27 Oct 2025
    Share Share
    Corsera launches with $50M for predictive AI tool, RNAi Asset
    Corsera launches with $50M for predictive AI tool, RNAi Asset

    02 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aiming-disrupt-cardiovascular-space-2-industry-vets-unveil-boston-biotech-preventative-rnai

    FIERCE BIOTECH
    02 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search